AKT1 and ovarian carcinoma: Our findings are consistent with this report where enhanced cytotoxic effects of RES on ovarian cancer cell upon cisplatin treatment can be explained by its ability to maintain the robust activation of p38 MAPK (while suppressing AKT activation), making the cancer cells more susceptible to apoptotic death induction.